Estimation the Biochemical parameters Changes in Blood of Corona Virus Patients in Iraq in Order to Support the Timely Decision Needs
Keywords:
Human infections, WilliamsonAbstract
People in every region of the globe are showing rapid signs of infection with the SARS-Cove-2 virus. One patient is able to transmit the virus to two or three more patients even if they are not showing any symptoms, which is proof of the virus's fast spread. The importance of knowing the values of these signs and ensuring their validity lies in supporting the doctor's decision-making at the right time to control the infection and detect cases that do not show symptoms of infection. As a result, it is simple to isolate infected cases and make the decision to treat them as soon as possible to reduce the risk of infection and disease outbreaks. Therefore, the objective of this paper is to evaluation biochemical parameters changes in blood of patients with corona virus. The indicators was estimated in the study include CRP, Creatinine, BUN, Sugar, WBC, cholesterol, HDL, D-Dimer, enzymes of liver function, and renal function tests. It is important to know and validate the values of the biochemical parameters in order to support the timely decision that the clinician needs to make in order to control infection and detect pathological conditions. Additionally, it is important to determine whether or not the values fall within the normal level or whether or not they fall within the level of the control group. Through our research, which describes the pathway for ESR, CRP, RBS, D-Dimer, and Ferritin, it is possible to understand the mechanism that influences the change in the levels of these parameters in patients with Covid 19 and thereby contribute to the early detection of the disease. According to the findings of these tests, there are high significant disparities between the patients. Additionally, this study demonstrated that there is a statistically significant gap between the patients and the control group. On the other hand, one of the most important diagnostic markers for COVID-19 sickness is the D-Dimer test in combination with the ferritin test.
References
Tang, N., Bai, H., Chen, X., Gong, J., Li, D. and Sun, Z. 2020. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. Journal of Thrombosis and Haemostasis, 18(5): 1094-1099.
McMichael, T. M., Currie, D. W., Clark, S., Pogosjans, S., Kay, M., Schwartz, N. G. and Duchin, J. S. 2020. Epidemiology of COVID-19 in a long-term care facility in King County, Washington. New England Journal of Medicine, 382(21): 2005-2011.
Munster, V. J., Koopmans, M., van Doremalen, N., van Riel, D. and de Wit, E. 2020. A novel coronavirus emerging in China key questions for impact assessment. New England Journal of Medicine, 382(8): 692-694.
Vilibic-Cavlek, T., Stevanovic, V., Tabain, I., Betica-Radic, L., Sabadi, D., Peric, L. and Barbic, L. 2020. Severe acute respiratory syndrome coronavirus 2 seroprevalence among personnel in the healthcare facilities of Croatia, 2020. Revista da Sociedade Brasileira de Medicina Tropical, 53, 130-134.
Glover, S. W. and Bowen, S. L. 2004. Bibliometric analysis of research published in Tropical Medicine and International Health 1996–2003. Tropical Medicine and International Health, 9(12): 1327-1330.
Cheng, Y., Luo, R., Wang, K., Zhang, M., Wang, Z., Dong, L. and Xu, G. 2020. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney International, 97(5): 829-838.
Zhou, P., Yang, X. L., Wang, X. G., Hu, B., Zhang, L., Zhang, W. and Shi, Z. L. 2020. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 579(7798): 270-273.
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y. and Zhang, L. 2020. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The lancet, 395(10223): 507-513.
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y. and Cao, B. 2020. Clinical features of patients infected with 2019 novel coronavirus in
Wuhan, China. The Lancet, 395(10223): 497-506.
Guan, W. J., Ni, Z. Y., Hu, Y., Liang, W. H., Ou, C. Q., He, J. X. and Zhong, N. S. 2020. Clinical characteristics of coronavirus disease 2019 in China. New England Journal of Medicine, 382(18): 1708-1720.
Mojtabavi, H., Saghazadeh, A. and Rezaei, N. 2020. Interleukin-6 and severe COVID-19: a systematic review and meta-analysis. European Cytokine Network, 31(2): 44-49.
Pozdnyakova, O., Connell, N. T., Battinelli, E. M., Connors, J. M., Fell, G. and Kim, A. S. 2021. Clinical significance of CBC and WBC morphology in the diagnosis and clinical course of COVID-19 infection. American Journal of Clinical Pathology, 155(3): 364-375.
Hachim, M. Y., Hachim, I. Y., Naeem, K. B., Hannawi, H., Salmi, I. A. and Hannawi, S. 2020. D-dimer, troponin, and urea level at presentation with COVID-19 can predict ICU admission: a single centered study. Frontiers in Medicine, 7: 585003.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 IJASRaR
This work is licensed under a Creative Commons Attribution 4.0 International License.
